AB0469 CLINICAL DISEASE MIGHT BE DIVIDED INTO TWO PHENOTYPES IN ANCA ASSOCIATED VASCULITIS; RESULTS OF A CLUSTER ANALYSIS

Abstract

Background:One of the controversial matters in ANCA associated vasculitis is the definition of disease based on clinical characteristics since there is remarkable overlap between disease groups. For instance, single organ disease like renal limited vasculitis (RLV) is not take place most of the definitions or classification criteria.Objectives:The aim of this study to determine clinical subgroups that may incorporate different clinical phenotypes including RLV in AAV patients followed up in two tertiary centers.Methods:Baseline clinical features of AAV patients were studied. To analyse our data and identify sub-groups of AAV patients with similar clinical characteristics, a two-step cluster analysis using log-likelihood distance measures was performed. For clustering we evaluated the following variables: gender, age at symptom onset, the presence of major organ involvement (renal, upper and lower respiratory tract, skin, joint, eye) and ANCA specificity.Results:In total 165 (87 [53%] male, age at diagnosis 51.6± 15.2 years) out of 238 (126 [53%] male, age at diagnosis 51.3± 15.6 years) AAV patients included in the analysis. Some of the demographic and clinical characteristics were summarized in the table 1. There are two distinct cluster in AAV patients. Of 78% those AAV patients with MPO/pANCA, 56% with renal involvement and 89% without ENT involvement were in Cluster 1. Of 77% those patients with PR3/cANCA, 89% with arthritis, 74% with eye involvement, 83% with skin, 91% with upper, and 60% with lower respiratory tract involvement and 92% of those without renal disease were in Cluster 2. Most of the (89%) patients classified as MPA and all as RLV were repositioned in Cluster 1 and 74% of GPA and 64% of EGPA patients were in Cluster 2.Table 1.Baseline characteristics of 165patients with AAVAge at diagnosis, mean years ± SD, (n)51.6 ±15.2, 163Male, n (%)87 (52.7)Labaratory results at diagnosisGFR =&lt;60, n (%)100/145 (69)MPO-ANCA or p-ANCA /Pr3-ANCA or c-ANCA68 (41.2)/ 97 (58.8)Variants of AAVn (%)MPA26(15.8)GPA108 (65.5)EGPA11 (6.7)RLV20 (12.1)Organ systems involved at diagnosis n (%)Cutaneous24 (14.5)Eye23 (13.9)Ear, nose and throat90 (54.5)Low respiratory tract111 (67.3)Cardiovascular system5/163 (3.1)Gastrointestinal system10/164 (6.1)Renal129 (78.2)Peripheral nervous system16 (9.7)GFR: glomeruler filtration rate; ANCA: antineutrophil cytoplasmic antibodies; Pr3: proteinase 3; MPO: myeloperoxidase; p-ANCA: perinuclear ANCA; c-ANCA: cytoplasmic ANCA; MPA: Microscopic Polyangiitis; GPA: Granulamatosis and Polyangiitis; EGPA:Eosinophilic Granulomatosis with Polyangiitis; RLV: Renal limited vasculitisConclusion:Patients with AAV could be separated into two distinct categories. PR3 ANCA specificity and more organ/system involvement determine one and MPO ANCA specificity in renal disease define other subgroup.Figure. Determining characteristics of ANCA associated vasculitis clustersFigure.Disclosure of Interests:None declared</jats:sec